Showing 1921-1930 of 5129 results for "".
Various Skin Cancer Therapies Covered at Maui Derm
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/various-skin-cancer-therapies-covered-at-maui-derm/32915/With a theme of understanding the various options available for treatment of skin cancers and selecting the correct ones for each case, George Martin, MD, Ted Rosen, MD, and Emily Ruiz, MD, MPH, presented “Cutaneous Oncology Update 2025” at the Maui Derm Hawaii 2025 meeting in Maui, Hawaii.More than Skin Deep: Sharing Stories for Mental Health
https://practicaldermatology.com/topics/general-topics/more-skin-deep-sharing-stories-mental-health/28860/Medical students Emily Woolhiser and Alexandra Lawlor highlight an empowering project seeking to address issues stemming from psychological issues due to dermatological conditions.GEP Testing for Cutaneous Squamous Cell Carcinoma
https://practicaldermatology.com/videos/updates-in-skin-cancer/gep-testing-for-cutaneous-squamous-cell-carcinoma/35599/Emily Ruiz, MD, MPH, FAAD, director of the High-Risk Cancer Clinic at Dana-Farber Cancer Institute, discusses utilizing gene expression profiling (GEP) to risk stratify tumors in cutaneous squamous cell carcinoma patients.DermWire TV Extra: Spironolactone on TikTok
https://practicaldermatology.com/videos/dermwire-tv/dermwire-tv-extra-spironolactone-on-tiktok/33016/George Washington University clinical instructor of Dermatology Emily Murphy, MD, and medical student Savanna Vidal discuss their research regarding the quality and reliability of information on TikTok about spironolactone for acne treatment.Cutaneous Oncology Update: Dr. Ruiz
https://practicaldermatology.com/programs/practical-dermatology/cutaneous-oncology-update-dr-ruiz/32696/Emily Ruiz, MD, discusses the key points she covered about nonmelanoma skin cancer during "Cutaneous Oncology Update 2025" at Maui Derm 2025, as well as her poster presentation on the 40-GEP test for head and neck cutaneous squamous cell carcinomas.Addressing the Psychologic Impact of Atopic Dermatitis on Pediatric Patients
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/addressing-the-psychologic-impact-of-atopic-dermatitis-on-pediatric-patients/37174/Elizabeth Lippner, MD, MA, Attending Physician in the Division of Allergy and Immunology and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine, describes the psychologic impact of atopic dermatitis on children and how clinicians can address these issues.Expanding the Role of Topicals in Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-updates-in-atopic-dermatitis/expanding-the-role-of-topicals-in-atopic-dermatitis/57282/Tina Bhutani-Jacques, MD, MAS, discusses how newer nonsteroidal topical therapies are changing the treatment paradigm in atopic dermatitis, expanding options for patients across disease severities and supporting long-term disease management.Transitioning From Academia to Private Practice
https://practicaldermatology.com/issues/august-2025/transitioning-from-academia-to-private-practice/36705/YoungMD Connect recently hosted an “Ask Me Anything” mentorship session with Tina Bhutani, MD, MAS, FAAD, during which she discussed her shift in career trajectory from academia to private practice and the insights she gained along the way.DermWire TV Extra: Dr. Ruiz on GEP Testing for SCC
https://practicaldermatology.com/topics/skin-of-color/dermwire-tv-extra-dr-ruiz-gep-testing-scc/29497/Emily Ruiz, MD, MPH, FAAD, a Mohs surgeon at Brigham and Women's Hospital and cutaneous oncologist at Dana-Farber Cancer Institute, discusses her recent Future Oncology article, "Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profile."Connective Tissue Disorders Update 2025: Dr. Vleugels
https://practicaldermatology.com/programs/practical-dermatology/connective-tissue-disorders-update-2025-dr-vleugels/32673/Ruth Ann Vleugels, MD, PhD, recaps her presentation, "Connective Tissue Disorders Update 2025" at Maui Derm 2025. Dr. Vleugels discussed a new therapeutic for systemic lupus, a new FDA-approved option for dermatomyositis, JAK inhibitors, and more.